Funders › MN › A Breath of Hope Lung Foundation › 2019
Grants paid by A Breath of Hope Lung Foundation, tax year 2019
EIN 30-0475578 · Bloomington, MN · Form 990, Schedule I · NTEE G123
In tax year 2019, A Breath of Hope Lung Foundation (EIN 30-0475578) reported 2 grants paid totaling $150,000. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2019
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2019 | Massachusetts Institute of Technology Cambridge, MA | A | $75,000 | paid | Lung cancer research grant: The research project funded by A Breath of Hope Lung Foundation is seeking to tackle a long-standing question on whether the heterogeneity of a tumor is impacting its immune response. Although often perceived as one disease, any cancer lesion is comprised of millions of tumor cells. While some tumor cells seem similar to others, they may be very different in their appearance to the immune system. This phenomenon of high intra-tumor heterogeneity is particularly common in lung cancer. Despite us knowing about the heterogeneity, we currently have no mechanistic understanding about its impact on anti-tumor immunity. Understanding this interplay will help find rational and potent combination treatments with cancer immunotherapy, a relatively new treatment modality activating the patients' own immune system to fight cancer. | 202001419349301465 |
| 2019 | University of Pittsburgh Pittsburgh, PA | A | $75,000 | paid | Lung cancer research grant: Lung cancer is the leading cause of cancer death in women, killing more women each year than breast, uterine and ovarian cancers combined. Sex differences in non-small cell lung cancer (NSCLC) and survival suggest that estrogen plays a critical factor in the formation of tumors in women's lungs. Preclinical and epidemiological studies have demonstrated that the estrogen pathway is a driver of NSCLC progression in women. Results of this project will provide a mechanistic understanding of the role of estrogen on immune suppression and whether hormonal blockade can improve the response rate or durability of response in women with this type of cancer that are treated with targeted immunotherapy. | 202001419349301465 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.